[1]
P. Fadakar, “Evaluation of SD-208, a TGF-β-RI Kinase Inhibitor, as an Anticancer Agent in Retinoblastoma”, Acta Med Iran, vol. 54, no. 6, pp. 352-358, Jun. 2016.